scispace - formally typeset
M

Meral Beksac

Researcher at Ankara University

Publications -  11
Citations -  249

Meral Beksac is an academic researcher from Ankara University. The author has contributed to research in topics: Multiple myeloma & Transplantation. The author has an hindex of 8, co-authored 11 publications receiving 156 citations.

Papers
More filters
Journal ArticleDOI

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.

Philippe Moreau, +69 more
- 01 Mar 2021 - 
TL;DR: The International Myeloma Working Group's clinical practice recommendations for the treatment of relapsed and refractory multiple myeloma were presented in this article, where the authors integrated the issue of drug access in both low-income and middle-income countries and in high income countries to help guide realworld practice and thus improve patient outcomes.
Journal ArticleDOI

Chronic graft-versus-host disease complicated by membranous glomerulonephritis

TL;DR: A mucosal form of cGVHD was diagnosed on the basis of clinical and biopsy findings and nephrotic administered for GVHD prophylaxis from day −1 to syndrome day +180 was administered.
Book ChapterDOI

HLA Typing with Sequence-Specific Oligonucleotide Primed PCR (PCR-SSO) and Use of the Luminex™ Technology

TL;DR: The hybridization products obtained by PCR using sequence-specific oligonucleotides (PCR-SSO) can be traced either by colorimetric- (streptavidin- biotin), X-ray-(digoxigenin-CSPD), or fluorescence- (FITC, PE) based detection systems.
Journal ArticleDOI

HLA polymorphism and risk of multiple myeloma.

TL;DR: The present study shows that secondary reference biological calibrators anchored to theWHO primary standards can decrease inter-laboratory variability and substantiate the objective initially set during the establishment of the WHO primary standards, that is, to facilitate worldwide diffusion of the IS.
Book ChapterDOI

HLA typing with sequence-specific oligonucleotide primed PCR (PCR-SSO) and use of the Luminex™ technology.

TL;DR: The hybridization products obtained by PCR using sequence-specific oligonucleotides can be traced either by colorimetric (streptavidin-biotin)-, X-ray (digoxigenin-CSPD)-, or fluorescence (FITC, PE)-based detection systems.